Neurosense Labs
We are one of the leading end to end healthcare solutions provider in India. We design, develop, and provide software solutions, including mobile and web applications, for healthcare services focusing on various health care issues. We provide digital solutions for various health issue and provide tools and technologies that aid in the diagnosis, treatment, and ongoing treatment of various health issues.
About Us
We engage in research, innovation, and development of new technologies, including artificial intelligence (AI), machine learning (ML), and behavioural analytics, in the context of providing healthcare interventions. We do this by leveraging a spectrum of disruptive technologies such as: Artificial Intelligence, Block Chain, Cloud, Digital Process Automation, Internet of things, Robotics, Virtual/Augmented Reality, etc..
Autism spectrum disorders (ASDs) are a group of neurodevelopmental abnormalities that begin in early childhood and are characterized by impairments in social interaction and communication, as well as repetitive behaviours and restricted interests [DSM-V].
In recent years, the prevalence of ASD has increased substantially. In the early 2000s, ASD was estimated to occur in approximately 1 in 150 children. As of 2023, this number has increased to approximately 1 in 36 children (Centers for Disease Control and Prevention, 2023). In India it’s 1 in 68 as of 2021 (Indian Journal of Pediatrics).
Research has shown early identification of ASD has resulted in an increased number of infants and toddlers seeking treatment from early intervention programs Access to early and appropriate intervention has the potential to impact and improve the child’s lifelong outcomes
ASD diagnoses may continue to rise
1
Several outcome studies have indicated that the best outcome is achieved when treatment is started as early as possible (before the age of 5) and with a high intensity (30–40 h per week). Early developmental behavioral intervention, the Early Start Denver Model (ESDM), resulted in gains in Cognitive, language and adaptive behavior of children with autism spectrum disorder.
2
Another study indicates that the average increased cost of treatment at younger ages was significantly smaller than the total savings in treatments at older ages, with children needing fewer sessions of ABA (Applied Behavior Analysis) / EIBI.
3
Early and Intensive Behavioral Intervention (EIBI)), occupational, physical and speech therapy services.
AI Screening Tool
Neurosense is enabling the care givers by providing an opportunity for early screening of children using cutting AI technology by providing a simple and easy to use app for screening.
This is a screeing tool which based on the parameters screened will inform the care givers whether the child falls in suspect category and will recommend the nearest available medical expert for further diagnosis.
Our Team
Alagiri G
Founder & Chief Executive Officer
Renukadevi Navaneethan
Co-Founder and Chief Technology Officer
Any Queries?
Fill out the form below to send us your questions or requests. Our team will get back to you as soon as possible.
183, Viveganandha Nagar, 5th St., Sithalapakkam, Chennai – 600126.